Clinical Trials

A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome

Our site has been identified for participation in an Interventional, Randomized Control Phase 3 Industry Sponsored Study to evaluate IVIG (Panzyga) effectiveness in PANS patients.  We are actively enrolling participants in this trial. 

Further information about the PANS IVIG Trial like inclusion criteria, outcome measures, etc can be found at Clinicaltrials.gov or on the ProPANS IVIG Study Page